novobiocin has been researched along with arbekacin* in 2 studies
2 other study(ies) available for novobiocin and arbekacin
| Article | Year |
|---|---|
Biological activities of pargamicin A, a novel cyclic peptide antibiotic from Amycolatopsis sp.
The time-kill studies using pargamicin A against Staphylococcus aureus and Enterococcus faecalis were performed. The effects of the incorporation of radioactive precursors into macromolecules, membrane potential and function using fluorescent dyes were also examined. These studies revealed that rapid bactericidal activity of pargamicin A correlates with the perturbation of bacterial cell membrane potential and membrane function. Topics: Actinomycetales; Anti-Bacterial Agents; Cell Membrane; Dibekacin; Enterococcus faecalis; Fluorescent Dyes; Membrane Potentials; Microbial Sensitivity Tests; Novobiocin; Peptides, Cyclic; Staphylococcus aureus; Vancomycin | 2010 |
Inhibition of SV40 DNA replication in vitro by 1-N-acyl-3"-N-(trifluoroacetyl) kanamycin.
A new antiviral aminoglycoside antibiotic, 1-N-eicosanoyl-3''-N-(trifluoroacetyl) kanamycin, was found to inhibit SV40 DNA replication in vitro. Several other aminoglycoside antibiotics examined did not exhibit a significant inhibition of SV40 DNA replication. The elongation of the SV40 DNA strand was profoundly affected by this agent. The degree of inhibition was decreased by increasing the amount of DNA template, but not by increasing the amount of enzyme. The inhibition of SV40 DNA replication is attributed to the interaction between the agent and the DNA template. Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Antiviral Agents; Aphidicolin; Deoxycytidine Monophosphate; Dibekacin; Diterpenes; DNA Replication; DNA, Viral; Haplorhini; Hygromycin B; Kanamycin; Nalidixic Acid; Novobiocin; Simian virus 40; Spectrophotometry; Streptomycin | 1986 |